Editorial

www.pitt.edu European Community concerted action on the epidemiology and prevention dementia group

Tang MX, Yaakov S, Marder K, Bell K, Gurland B, Lantigua R, Andrews H, Feng L, Tycko B, Mayeux R. The APOE-4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and Hispanics. JAMA. 1998;279:751-755.

Gooding MP, Amaya E, Parra M y Rios AM. Prevalencia de las demencias en el municipio de Neiva 2003-2005. Acta Neurol Col 2006:22;243-248.

Pradilla G, Vesga ME, Leon-S FE, Grupo Geneco. National neuroepidemiological study in Colombia (EPINEURO)] Am J Public Health 2003;14:104-111.

Lopera F, Ardilla A, Martinez A, et al. Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. JAMA 1997: 12;277:793-9.

Arboleda GH, Yunis JJ, Pardo R, et al. Apolipoprotein E genotyping in a sample of colombian patients with Alzheimer´s disease. Neurosci Lett 2001: 305,135-138.

Hernandez L, Gámez A, Montañez P. Desempeño cognoscitivo en adultos sanos mayores de diferente escolaridad en Colombia. En prensa).

Demyttenaere K, Bruffaerts R, Posada-Villa J, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 291, 2581-2590.

Uhl GR, Grow RW. The burden of complex genetics in brain disorders. Arch Gen Psychiatry 2004: 61;223-229.

Camelo D, Arboleda G, Yunis JJ, et al. Angiotensin- converting enzyme and alpha 2 macroglobulin gene polymorphisms are not associates with Alzheimer´s disease in Colombian patients. J Neurol Sci 2004, 218: 47-51.

Parra-Bonilla G, Arboleda G, Yunis JJ, et al. Haplogroup analysis of the risk associated with APOE promoter polymorphisms in Colombian Alzheimer´s disease patients. Neurosci Lett 2003; 349: 159-162.

Forero D, Benítez B, Arboleda G, et al. Analysis of functional polymorphisms in three synaptic plasticity-related genes en alzheimer´s disease en Colombia. Neuroscience Research 2006; 55: 334-341.